March 2019 Awareness Night Prostate Cancer Genetics: Where are we now? Justin Lorentz MSc, CGC Cancer Genetic Counsellor Lead,Male Oncology Research and Education (MORE) Dept of Radiation Oncology, Sunnybrook Odette Cancer Centre CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 41:24 minutes
Awareness: The PCCN-Toronto and Side by Side Prostate Cancer Support Groups Newsletter. In this Issue: Do It For Dads Walk/Run on Father’s Day – Sunday June 16, 2019 Sponsors back again in 2019 – Thank you Miscellaneous Notes Our next Awareness Night – May 2019 PCCN-Toronto celebrating our 25th year including a bit of history PCC celebrating 25 years in 2019 Ask the Health Care Team – “Prostate cancer and prostate enlargement (BPH) – what’s the connection” by Dr. Sharon Sharir (Humber River Regional Hospital) Our 2019 Awareness Nights lineup On going projects Read it by clicking the link below …
It will hardly come as a surprise to most prostate cancer support group leaders and other prostate cancer advocates that there is a strong association between patient age and risk for side effects of radical prostatectomy. However, we now have a rather more sophisticated set of insight into such risks. Read the article.
Data from the survival outcomes of patients support the use of active surveillance in low risk and intermediate risk cases of Gleason 6 but not Gleason 7 prostate cancer. Multiparametric magnetic resonance imaging and novel biomarkers might be vital in detecting favorable Gleason 7 disease. Read the article here.
A recent large U.S. study designed to gauge the health benefits of vitamin D and fish oil supplements concludes that the omega-3 oil can dramatically reduce the odds of a heart attack while vitamin D’s benefits seem to come from lowering the risk of death from cancer. Neither vitamin D nor fish oil lowered the odds of stroke or of getting cancer in the first place in the trial. Read the article here.